David W Goodrich

16PUBLICATIONS
116CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Micro-manipulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 01, 2026
Single-cell profiling uncovers a rare mesenchymal-like urothelial state associated with sarcomatoid bladder cancer.

|Aug 31, 2026
Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Nov 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.

Justine J Jacobi, Kristine M Wadosky, Neha Jaiswal

|Aug 08, 2025
Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation.

Ricardo A Cordova, May Elbanna, Christopher Rupert

|Apr 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles.

Candice L Bizzaro, Camila A Bach, Ricardo A Santos

Pageof 3

Frequent Collaborators

4 joint publications

Justine Jacobi

2 joint publications

Angela J Klunk

2 joint publications

Alessandro Fatatis

2 joint publications

Ronald C Wek